Amgen, Inc. (NASDAQ:AMGN) released its earnings results on Tuesday, April, 30th. The medical research company reported $3.56 EPS for the quarter, beating the consensus estimate of $3.45 by $0.11. The medical research company earned $5.56 billion during the quarter, compared to analysts' expectations of $5.55 billion. Amgen had a return on equity of 67.08% and a net margin of 34.00%. The company's quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.47 earnings per share.
NASDAQ:AMGN - Stock Price, News, & Analysis for Amgen | MarketBeat